Piper Sandler Sees Record Bank M&A Closings, Booming Debt Capital Markets But Warns Q2 Market Share Dip
Piper Sandler reported a strong Q1 with record bank M&A closings and robust Debt Capital Markets advisory performance driven by significant volume and volatility-related hedging transactions. Equity capital markets revenues surged in Healthcare but executives cautioned that outsized market share gains and large deal pipelines may not persist into Q2.
1. Bank M&A and Hedging Activity
Piper Sandler closed a significant number of bank M&A deals in Q1, with smaller transactions offsetting a slowdown in larger announced deals. The firm’s derivative desk saw heightened hedging volume as rate volatility spurred both client discussions and completed transactions.
2. Healthcare Equity Capital Markets
Healthcare led equity capital markets revenues, driven by several large fees that boosted market share in Q1. Management noted that the biotech sector’s unique trading patterns supported this surge but cautioned that such outsized market share gains may not repeat.
3. Advisory Outlook and Sector Variations
Advisory fees are expected to decline sequentially amid a choppy macro environment, with banks and sponsor-backed deals slowing execution. Exceptional performance in Healthcare and Medtech in Q1 was hard to replicate, and sponsors continue to pitch transactions without immediate urgency to transact.
4. Non-M&A Businesses Performance
Debt Capital Markets advisory delivered an outsized Q1 performance, marking a bright spot beyond M&A. Restructuring and private capital advisory also contributed, with private capital advisory showing encouraging growth following the recent acquisition integration.